| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $204.0M | +13.3% |
| Cost of Revenue | $17.8M | -0.7% |
| R&D Expense | $477.4M | -20.6% |
| SG&A Expense | $237.4M | +21.5% |
| Pre-tax Income | -$552.3M | +13.9% |
| Income Tax | $5.2M | +74.5% |
| Net Income | -$557.5M | +13.4% |
| EPS (Basic) | -$9.35 | +15.1% |
| EPS (Diluted) | -$9.35 | +15.1% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $119.7M | -43.0% |
| Accounts Receivable | $23.5M | -6.5% |
| Inventory | $29.7M | +36.1% |
| Current Assets | $1.05B | +88.9% |
| Total Assets | $1.35B | +7.8% |
| Current Liabilities | $183.2M | +22.3% |
| Total Liabilities | $835.2M | +196.7% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$502.3M | -68.2% |
| Capital Expenditures | $8.9M | +188.7% |
| Investing Cash Flow | -$149.5M | +33.8% |
| Financing Cash Flow | $561.8M | +1007.8% |
| Free Cash Flow | -$511.2M | -69.4% |
| Stockholders' Equity |
| $514.7M |
| -47.0% |